Innovations in Clinical Practice

Innovations in Clinical Practice

Innovations in Clinical Practice (ICP) submissions address improvements in the delivery of healthcare in outpatient, inpatient, or community-based settings. Appropriate topics include quality improvement and patient safety initiatives, implementation of innovative clinical programs (e.g., medical home and chronic care delivery models), applied informatics in healthcare, systems engineering, translating research into practice, methods to effect changes in clinicians’ behavior, and strategies to enhance cost-effectiveness. Unlike scientific abstracts, ICP submissions are not required to have complete evaluation data but should include a discussion of proposed metrics. This can include qualitative or quantitative measures. Submissions with evaluation data, whether qualitative or quantitative, may receive higher ratings. Submissions should include enough information about the intervention for session attendees to evaluate reproducibility and feasibility of the intervention at their practice or community.

 

KEY DATES SUBMISSION WEBSITE SUBMISSION FAQ

November 16, 2017: Submission opens ($75)
December 7, 2017 9:00 AM ET: Submission fee increases ($85)
January 4, 2018 9:00 AM ET: Submission closes
February 8, 2018: Acceptance notifications emailed
February 15, 2018: Early Registration Deadline
February 17, 2018 at 9:00 AM ET: RSVP Invitations due



Peer Review Criteria



January 9, 2018: Peer Review Period Opens
January 23, 2018 at 9:00 AM ET: Peer Review Period Closes


Peer Review Criteria

Panels of SGIM member volunteers will review all submissions. Reviewers will be blinded to author(s) and institution(s) during the review process. Clinical Practice Innovations submissions will be rated and ranked using the following criteria.

  1. Relevance/Importance:
    • Saliency of topic to clinical practice of general internal medicine
  2. Creativity/Originality:
    • Degree to which concept or approach is original
  3. Methods:
    • Appropriateness of intervention design and qualitative or quantitative methods used to assess impact of intervention on stated outcomes of interest
  4. Findings/Measures of Success:
    • Appropriateness of choice of measurement, clarity of findings
  5. Feasibility/Generalizability:
    • Degree to which results may be applied in other institution

Peer Review Rubric


Peer Review Instructions



Submission Criteria


See ICP submission criteria below.


New for 2018: Innovations In Clinical Practice Hands-On Tech Submissions

    In addition to submitting as a poster presentation or oral presentation, presenters will have the opportunity to demonstrate a piece of technology being used (e.g. app, mobile health device, clinical decision support tool, etc.) to improve the delivery of healthcare during a special hands-on session.  Submissions may include technology development by the presenter or an innovative use of implementation of technology developed by others. "Hands-on Tech" presenters must be SGIM members and submissions must conform to the presentation requirements.

    • If accepted, presenters must be available during the only ICP Poster Session on Thursday, April 12, 2018 to present from 2:15 PM - 3:45 PM (90 minutes). Rescheduling requests cannot be accommodated.
    • A 6' L x 2' W skirted table will be provided.  The piece of technology must fit within this space.
    • Power outlets and Wi-Fi to all meeting attendees will be provided during this session but presenters are responsible for any other technical or audiovisual equipment that they may need.
    • Shipping and storage of equipment must be managed independently by the presenter. Shipping and delivery of equipment services are available through the Business Center of the Annual Meeting headquarters hotel.
    • A 4'H x 8' W poster board will be placed behind the table. Presenters must provide a poster describing the innovation. 

    If you would like to submit an ICP abstract that includes a technology demonstration, please check the box titled "Hands-on Tech" during the abstract submission process in Step 3: Details


    Submission Length

     Innovations in Clinical Practice submissions are limited to 3,000 characters, including spaces.

    Maximum character count limit applies only to these sections:
    • Statement of Problem or Question (one sentence)
    • Objectives of Program/Intervention (no more than three objectives)
    • Description of Program/Intervention, including organizational context (e.g., inpatient vs. outpatient, practice or community characteristics)
    • Measures of success (discuss qualitative or quantitative metrics that will be used to evaluate program/intervention)
    • Findings to Date (it is not sufficient to state "findings will be discussed")
    • Key Lessons for Dissemination (what can others take away for implementation to their practice or community?)

     Submission Structure

    1. Title (No all caps, quotes, underlining, or bolding.)
    2. Statement of Problem or Question (One sentence.)
    3. Objectives of Program/Intervention (No more than three objectives.)
    4. Description of Program/Intervention (Include organizational context: e.g., inpatient vs. outpatient, practice or community characteristics.)
    5. Measures of Success (Discuss qualitative or quantitative metrics that will be used to evaluate program/intervention.)
    6. Findings to Date (It is not insufficient to state “findings will be discussed.”)
    7. Key Lessons for Dissemination (what can others take away for implementation to their practice or community?)
    8. Presentation Format Preference (Presentation Only, Poster Presentation Only or No Preference. See below.)
    9. Theme Related Submission (Does this submission content relate to the meeting theme? This information is not part of the peer review process. If accepted, your response may impact the scheduling of your presentation. Yes/No.)
    10. Poster Walk-Through Participation (Optional. See below.)
    11. Scheduling Restrictions (If accepted to present from Round One, please identify scheduling conflicts. See below.)
    12. Non-Commercial Funding Source (Optional. See below.)
    13. Policy Verification (Confirm understanding of Submission Policies & Presenter Register Policy.)
    14. Accuracy (Confirm accuracy of information submitted.)
    15. Authors (Name, Institution, City/State, Email)

     Presentation Format

    Identify your preference for presentation format:

    • Oral Presentation Only
    • Poster Presentation Only
    • No Preference

    Format choice matters:

    • SGIM schedules accepted submissions based on the results of the peer review process. The most highly rated submissions are scheduled for an oral presentation followed by those rated highly enough for presentation as posters.
    • We recommend stipulating “no preference”, as it will increase the likelihood of your submission being accepted.
    • If you stipulate “oral presentation only” and your submission is only ranked highly enough for a poster presentation, you will receive a rejection notification.
    • Submissions funded through direct commercial support should select “poster only” as their choice, as poster sessions do not offer CME credit hours.

    Poster Walk-Through Participation

    Optional. If accepted for poster presentation, do we have your permission to schedule you to participate in a walk-through? A walk-through session will include an expert in your identified category bringing a small group of attendees around to discuss your work. (Yes/No)


    ICP Scheduling & Scheduling Restrictions for Presenting Authors

    There is only one ICP Poster Session:

    1. Session E: Thursday, April 12, 2018, 2:15–3:45 PM.
    There are two ICP Oral Presentation Sessions:
    1. Session M: Friday, April 12, 2018, 2:15–3:15 PM
    2. Session P: Saturday, April 13, 2018, 10:15–11:15 AM

    Scheduling Restrictions for Presenting Authors

    If accepted as a poster, rescheduling requests cannot be accommodated due to limited programming.

    If accepted as an oral presentation, rescheduling requests can only be accommodated within the two ICP Oral Presentation Sessions. The program committee will make every effort, but cannot guarantee, to avoid all scheduling conflicts.


    Non-Commercial Funding Source

    Choose as many as apply:

    • VA Funding
    • AHRQ Funding
    • DOD Funding
    • NIH Funding
    • PCORI Research Grant
    • RWJ Foundation


     Submission & Presentation Tips

    Designing a Poster 


    Topic and Intended Audience

    Know your topic and your intended audience:

    • Which attendees are your primary target audience?
    • Why is this important to them?
    • Will it stimulate excitement?
    • Is the topic timely?
    • Does it help audience members meet an urgent need? (e.g. accreditation issues)
    • How much time does your topic require?
    • Choose the most appropriate category for submission. Then identify as many tracks as you think apply.